Skip to main content
Erschienen in: Journal of Nephrology 3/2018

01.06.2018 | Original Article

Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits

verfasst von: Andrea Ticinesi, Angela Guerra, Franca Allegri, Antonio Nouvenne, Gianfranco Cervellin, Marcello Maggio, Fulvio Lauretani, Loris Borghi, Tiziana Meschi

Erschienen in: Journal of Nephrology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The association of metabolic syndrome (MetS) traits with urinary calcium (UCE) or oxalate excretion (UOE) is uncertain in calcium stone formers (CSFs). Our aim was to investigate this association in a large group of Caucasian CSFs.

Methods

We retrospectively reviewed data of CSFs evaluated at our Kidney Stone Clinic from 1984 to 2015. Data on body mass index (BMI), MetS traits defined according to international consensus, family history of urolithiasis, anti-hypertensive treatments, calcemia, renal function, and 24-h urinary profile of lithogenic risk were collected. The association between MetS traits and UCE or UOE was tested with multivariate linear regression models accounting for a long list of potential confounders.

Results

We included 3003 CSFs, aged 44 ± 14 years. The prevalence of hypertension, diabetes, overweight (BMI ≥ 25 kg/m2) and dyslipidemia was 17, 2, 42 and 38%, respectively. Median values of UCE and UOE were 211 mg/24 h (IQR 143–296) and 28 mg/24 h (IQR 22–34), respectively. At a multivariate model, including age, sex, date of examination, drug treatments, family history, renal function, blood calcium and urinary factors as covariates, hypertension was a significant positive determinant of UCE (β ± SE 0.23 ± 0.07, p = 0.003), but overweight, dyslipidemia and diabetes were not. No MetS trait was significantly associated with UOE in multivariate models.

Conclusions

In a large group of Caucasian CSFs, hypertension was the only MetS trait significantly associated with UCE, while no MetS trait was associated with oxalate excretion.
Literatur
1.
Zurück zum Zitat Jeong IG, Kang T, Bang JK, Park J, Kim W, Hwang SS, Kim HK, Park HK (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383–388CrossRefPubMed Jeong IG, Kang T, Bang JK, Park J, Kim W, Hwang SS, Kim HK, Park HK (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383–388CrossRefPubMed
2.
Zurück zum Zitat West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51:741–747CrossRefPubMed West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51:741–747CrossRefPubMed
3.
Zurück zum Zitat Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura M, Inagaki T, Hara I (2013) Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis 61:923–929CrossRefPubMed Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura M, Inagaki T, Hara I (2013) Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis 61:923–929CrossRefPubMed
5.
Zurück zum Zitat Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59:2290–2298CrossRefPubMed Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59:2290–2298CrossRefPubMed
6.
Zurück zum Zitat Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73:489–496CrossRefPubMed Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73:489–496CrossRefPubMed
7.
Zurück zum Zitat Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257–264CrossRefPubMed Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257–264CrossRefPubMed
8.
Zurück zum Zitat Sakhaee K, Capolongo G, Maalouf NM, Pasch A, Moe OW, Poindexter J, Adams-Huet B (2012) Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transpl 27:3201–3209CrossRef Sakhaee K, Capolongo G, Maalouf NM, Pasch A, Moe OW, Poindexter J, Adams-Huet B (2012) Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transpl 27:3201–3209CrossRef
10.
Zurück zum Zitat Nouvenne A, Ticinesi A, Allegri F, Guerra A, Guida L, Morelli I, Borghi L, Meschi T (2014) Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed? Clin Chem Lab Med 52:337–344CrossRefPubMed Nouvenne A, Ticinesi A, Allegri F, Guerra A, Guida L, Morelli I, Borghi L, Meschi T (2014) Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed? Clin Chem Lab Med 52:337–344CrossRefPubMed
11.
Zurück zum Zitat Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29:715–734CrossRefPubMedPubMedCentral Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29:715–734CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645CrossRefPubMed Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645CrossRefPubMed
13.
Zurück zum Zitat Barreira TV, Staiano AE, Harrington DM, Heymsfield SB, Smith SR, Bouchard C, Katzmarczyk PT (2012) Anthropometric correlates of total body fat, abdominal adiposity, and cardiovascular disease risk factors in a biracial sample of men and women. Mayo Clin Proc 87:452–460CrossRefPubMedPubMedCentral Barreira TV, Staiano AE, Harrington DM, Heymsfield SB, Smith SR, Bouchard C, Katzmarczyk PT (2012) Anthropometric correlates of total body fat, abdominal adiposity, and cardiovascular disease risk factors in a biracial sample of men and women. Mayo Clin Proc 87:452–460CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Prezioso S, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Gambaro G, Gelosa M, Guttilla A, Illiano E, Marangella M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F (2015) Dietary treatment of urinary risk factors for renal stone formation. A review of CLU working group. Arch Ital Urol Androl 87:105–120CrossRefPubMed Prezioso S, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Gambaro G, Gelosa M, Guttilla A, Illiano E, Marangella M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F (2015) Dietary treatment of urinary risk factors for renal stone formation. A review of CLU working group. Arch Ital Urol Androl 87:105–120CrossRefPubMed
15.
Zurück zum Zitat Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397–2406CrossRefPubMed Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397–2406CrossRefPubMed
16.
Zurück zum Zitat Eisner BH, Porten SP, Bechis SK, Stoller ML (2010) Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol 183:576–579CrossRefPubMed Eisner BH, Porten SP, Bechis SK, Stoller ML (2010) Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol 183:576–579CrossRefPubMed
17.
Zurück zum Zitat Ticinesi A, Nouvenne A, Maalouf NM, Borghi L, Meschi T (2016) Salt and nephrolithiasis. Nephrol Dial Transplant 31:39–45CrossRef Ticinesi A, Nouvenne A, Maalouf NM, Borghi L, Meschi T (2016) Salt and nephrolithiasis. Nephrol Dial Transplant 31:39–45CrossRef
18.
Zurück zum Zitat Levy FL, Adams-Huet B, Pak CY (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98:50–59CrossRefPubMed Levy FL, Adams-Huet B, Pak CY (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98:50–59CrossRefPubMed
19.
Zurück zum Zitat Guerra A, Folesani G, Nouvenne A, Ticinesi A, Allegri F, Pinelli S, Prati B, Morelli I, Guida L, Aloe R, Meschi T (2016) Family history influences clinical course of idiopathic calcium nephrolithiasis: case-control study of a large cohort of Italian patients. J Nephrol 29:645–651CrossRefPubMed Guerra A, Folesani G, Nouvenne A, Ticinesi A, Allegri F, Pinelli S, Prati B, Morelli I, Guida L, Aloe R, Meschi T (2016) Family history influences clinical course of idiopathic calcium nephrolithiasis: case-control study of a large cohort of Italian patients. J Nephrol 29:645–651CrossRefPubMed
20.
Zurück zum Zitat Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC (1998) Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 32:802–807CrossRefPubMed Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC (1998) Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 32:802–807CrossRefPubMed
21.
Zurück zum Zitat Madore F, Stampfer MJ, Rimm EB, Curhan GC (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46–53CrossRefPubMed Madore F, Stampfer MJ, Rimm EB, Curhan GC (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46–53CrossRefPubMed
22.
Zurück zum Zitat Taylor EN, Mount DB, Forman JP, Curhan GC (2006) Association of prevalent hypertension with 24-h urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 47:780–789CrossRefPubMed Taylor EN, Mount DB, Forman JP, Curhan GC (2006) Association of prevalent hypertension with 24-h urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 47:780–789CrossRefPubMed
23.
Zurück zum Zitat Kim YJ, Kim CH, Sung EJ, Kim SR, Shin HC, Jung WJ (2013) Association of nephrolithiasis with metabolic syndrome and its components. Metabolism 62:808–813CrossRefPubMed Kim YJ, Kim CH, Sung EJ, Kim SR, Shin HC, Jung WJ (2013) Association of nephrolithiasis with metabolic syndrome and its components. Metabolism 62:808–813CrossRefPubMed
24.
Zurück zum Zitat Miranda Torricelli FC, De SK, Gebreselassie S, Sarkissian C, Monga M (2014) Dyslipidemia and kidney stone risk. J Urol 191:667–672CrossRef Miranda Torricelli FC, De SK, Gebreselassie S, Sarkissian C, Monga M (2014) Dyslipidemia and kidney stone risk. J Urol 191:667–672CrossRef
25.
Zurück zum Zitat Eisner BH, Eisenberg ML, Stoller ML (2010) Relationship between body mass index and quantitative 24-h urine chemistries in patients with nephrolithiasis. Urology 75:1289–1293CrossRefPubMed Eisner BH, Eisenberg ML, Stoller ML (2010) Relationship between body mass index and quantitative 24-h urine chemistries in patients with nephrolithiasis. Urology 75:1289–1293CrossRefPubMed
26.
Zurück zum Zitat Shavit L, Ferraro PM, Johri N, Robertson W, Walsh SB, Moochhala S, Unwin R (2015) Effect of being overweight on urinary metabolic risk factors for kidney stone formation. Nephrol Dial Transplant 30:607–613CrossRefPubMed Shavit L, Ferraro PM, Johri N, Robertson W, Walsh SB, Moochhala S, Unwin R (2015) Effect of being overweight on urinary metabolic risk factors for kidney stone formation. Nephrol Dial Transplant 30:607–613CrossRefPubMed
27.
Zurück zum Zitat Nouvenne A, Ticinesi A, Guerra A, Folesani G, Allegri F, Pinelli S, Baroni P, Pedrazzoni M, Lippi G, Terranegra A, Dogliotti E, Soldati L, Borghi L, Meschi T (2013) Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women. J Transl Med 11:248CrossRefPubMedPubMedCentral Nouvenne A, Ticinesi A, Guerra A, Folesani G, Allegri F, Pinelli S, Baroni P, Pedrazzoni M, Lippi G, Terranegra A, Dogliotti E, Soldati L, Borghi L, Meschi T (2013) Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women. J Transl Med 11:248CrossRefPubMedPubMedCentral
28.
29.
Zurück zum Zitat Yoon V, Adams-Huet B, Sakhaee K, Maalouf NM (2013) Hyperinsulinemia and urinary calcium excretion in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 98:2589–2594CrossRefPubMedPubMedCentral Yoon V, Adams-Huet B, Sakhaee K, Maalouf NM (2013) Hyperinsulinemia and urinary calcium excretion in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 98:2589–2594CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Eisner BH, Porten SP, Bechis SK, Stoller ML (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244–2248CrossRefPubMed Eisner BH, Porten SP, Bechis SK, Stoller ML (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244–2248CrossRefPubMed
31.
Zurück zum Zitat Bobulescu IA, Maalouf NM, Capolongo G, Adams-Huet B, Rosenthal TR, Moe OW, Sakhaee K (2013) Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol 305:F1498–F1503CrossRefPubMedPubMedCentral Bobulescu IA, Maalouf NM, Capolongo G, Adams-Huet B, Rosenthal TR, Moe OW, Sakhaee K (2013) Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol 305:F1498–F1503CrossRefPubMedPubMedCentral
Metadaten
Titel
Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits
verfasst von
Andrea Ticinesi
Angela Guerra
Franca Allegri
Antonio Nouvenne
Gianfranco Cervellin
Marcello Maggio
Fulvio Lauretani
Loris Borghi
Tiziana Meschi
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 3/2018
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-017-0453-3

Weitere Artikel der Ausgabe 3/2018

Journal of Nephrology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.